DuPont de Nemours, Inc. DD has registered a fourth-quarter 2025 loss from continuing operations of $108 million or 27 cents per share. In the year-ago quarter, the company recorded a loss of $291 million or 70 cents per share.
Barring one-time items, earnings came in at 46 cents per share in the reported quarter, topping the Zacks Consensus Estimate of 43 cents.
DuPont's net sales reached $1,693 million, essentially flat year over year and surpassing the Zacks Consensus Estimate of $1,684.1 million. Organic sales fell 1%. Sales were flat, as a 1% year-over-year decrease in volume and flat pricing were offset by a positive foreign-currency impact of 1%.

DuPont de Nemours, Inc. price-consensus-eps-surprise-chart | DuPont de Nemours, Inc. Quote
The Healthcare & Water Technologies segment recorded net sales of $821 million in the reported quarter, up 4% on a year-over-year basis. Organic sales grew 3%, along with 1% benefit from currency. Healthcare Technologies delivered mid-single-digit organic growth, with strength in medical packaging and medical devices. Water Technologies sales rose in the low-single-digit range on an organic basis.
The Diversified Industrials segment recorded net sales of $872 million, down 3% year over year. Organic sales dipped 4% but were partially offset by a 1% benefit from currency. Building Technologies were down in the high-single-digit range on an organic basis due to weakness in construction markets. Industrial Technologies sales were down in the low-single-digit range on an organic basis.
DuPont had cash and cash equivalents of $715 million at the end of the quarter, down around 60% year over year. Long-term debt was $3,134 million, down about 41%.
The company generated an operating cash flow from continuing operations of $560 million for the year ended Dec. 31, 2025.
For the first quarter of 2026, the company expects net sales of $1,670 million, operating EBITDA of $395 million and adjusted earnings per share (EPS) of 48 cents. For 2026, net sales are projected at $7,075-$7,135 million, with operating EBITDA estimated at $1,725-$1,755 million and adjusted EPS expected to be $2.25-$2.30.
DuPont’s shares have lost 42.2% in a year compared with a 13.5% decline in the industry.

DD currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Albemarle Corporation ALB, Coeur Mining, Inc. CDE and Avino Silver & Gold Mines Ltd. ASM.
Albemarle is slated to report fourth-quarter results on Feb. 11. The Zacks Consensus Estimate for earnings is pegged at a loss of 40 cents. ALB beat the Zacks Consensus Estimate in three of the last four quarters, while missing once, the average earnings surprise being 35.28%. ALB sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Coeur is scheduled to report fourth-quarter results on Feb. 18. The Zacks Consensus Estimate for CDE’s fourth-quarter earnings is pegged at 42 cents. CDE beat the Zacks Consensus Estimate in three of the last two quarters and missed once, the average earnings surprise being 106.61%. CDE currently flaunts a Zacks Rank #1.
Avino Silver is slated to report fourth-quarter results on March 11. The consensus estimate for ASM’s earnings is pegged at 6 cents. ASM, presently carrying a Zacks Rank #2 (Buy), beat the consensus estimate in the last four quarters, the average earnings surprise being 150%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-26 | |
| Aug-26 | |
| Aug-25 | |
| Aug-21 | |
| Aug-20 | |
| Aug-17 | |
| Aug-14 | |
| Aug-14 | |
| Aug-13 | |
| Aug-13 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 | |
| Aug-11 | |
| Aug-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite